Related references
Note: Only part of the references are listed.Inhaled Medicines: Past, Present, and Future
Sandra Anderson et al.
PHARMACOLOGICAL REVIEWS (2022)
Treprostinil palmitil inhibits the hemodynamic and histopathological changes in the pulmonary vasculature and heart in an animal model of pulmonary arterial hypertension
Michel R. Corboz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension
Adam J. Plaunt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Safety, tolerability, and pharmacokinetics (PK) of treprostinil palmitil inhalation powder (TPIP): a phase 1, randomised, double-blind, single- and multiple-dose study
F A Ismat et al.
EUROPEAN HEART JOURNAL (2021)
Fabrication of Zein-Lecithin-EGCG complex nanoparticles: Characterization, controlled release in simulated gastrointestinal digestion
Hujun Xie et al.
FOOD CHEMISTRY (2021)
Modeling of a spray drying method to produce ciprofloxacin nanocrystals inside the liposomes utilizing a response surface methodology: Box-Behnken experimental design
Isra Khatib et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Application of nanotechnology in drug delivery systems for respiratory diseases
Ming-Xin Luo et al.
MOLECULAR MEDICINE REPORTS (2021)
Comparative bioavailability of inhaled treprostinil administered as LIQ861 and Tyvaso® in healthy subjects
Robert F. Roscigno et al.
VASCULAR PHARMACOLOGY (2021)
Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections
Adam J. Plaunt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure
David E. Griffith et al.
CHEST (2021)
Intracellular Accumulation of Novel and Clinically Used TB Drugs Potentiates Intracellular Synergy
Lloyd Tanner et al.
MICROBIOLOGY SPECTRUM (2021)
Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology
Zhili Li et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
Nanoparticle-Based Drug Delivery System: The Magic Bullet for the Treatment of Chronic Pulmonary Diseases
Sheersha Pramanik et al.
MOLECULAR PHARMACEUTICS (2021)
Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease A 12-Month Open-Label Extension Clinical Trial
Kevin L. Winthrop et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)
Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil
Richard W. Chapman et al.
ERJ OPEN RESEARCH (2021)
Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension
Ali Keshavarz et al.
EXPERT OPINION ON DRUG DELIVERY (2020)
Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine
Corry-Anke Brandsma et al.
JOURNAL OF PATHOLOGY (2020)
Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases
Yudi Deng et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Post-inhalation cough with therapeutic aerosols: Formulation considerations
Sawittree Sahakijpijarn et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Localization of Macrophages in the Human Lung via Design-based Stereology
Patrick S. Hume et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Reflections on Digital Health Tools for Respiratory Applications
Andy Dundon et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2020)
Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and-4 studies
James D. Chalmers et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Pseudomonas AeruginosaInduced Cell Death in Acute Lung Injury and Acute Respiratory Distress Syndrome
Rushikesh Deshpande et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
An overview of the biology of a long-acting inhaled treprostinil prodrug
Richard W. Chapman et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2020)
Pharmacokinetics and tolerability of LIQ861, a novel dry-powder formulation of treprostinil
Robert Roscigno et al.
PULMONARY CIRCULATION (2020)
Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models
Suraj U. Hettiarachchi et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Danger-associated metabolic modifications during bacterial infection of macrophages
Mariatou Drame et al.
INTERNATIONAL IMMUNOLOGY (2020)
A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis
Pauline T. Lukey et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Acute respiratory distress syndrome
Michael A. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Muco-Obstructive Lung Diseases
Richard C. Boucher
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review
Omar Abdifetah et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
P1938In vitro characterization of a novel PI 3-kinase inhibitor for growth factor-induced effects in pulmonary artery smooth muscle cells
E M Berghausen et al.
EUROPEAN HEART JOURNAL (2019)
Current Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension
Kazufumi Nakamura et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
Charles S. Haworth et al.
LANCET RESPIRATORY MEDICINE (2019)
Orotracheal treprostinil administration attenuates bleomycin-induced lung injury, vascular remodeling, and fibrosis in mice
Ioanna Nikitopoulou et al.
PULMONARY CIRCULATION (2019)
Therapeutic efficacy of nanoparticles and routes of administration
Dhrisya Chenthamara et al.
BIOMATERIALS RESEARCH (2019)
The expanding role of prodrugs in contemporary drug design and development
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Idiopathic Pulmonary Fibrosis
David J. Lederer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Inhaled hexadecyl-treprostinil provides pulmonary vasodilator activity at significantly lower plasma concentrations than infused treprostinil
Richard W. Chapman et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2018)
Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats
Michel R. Corboz et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2018)
Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
Jimin Zhang et al.
FRONTIERS IN MICROBIOLOGY (2018)
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT)
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Drug nanocrystallisation within liposomes
Tang Li et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Zein/diclofenac sodium coprecipitation at micrometric and nanometric range by supercritical antisolvent processing
Paola Franco et al.
JOURNAL OF CO2 UTILIZATION (2018)
Idiopathic Pulmonary Fibrosis (IPF): An Overview
Shaney L. Barratt et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis
Carlo C. Campa et al.
NATURE COMMUNICATIONS (2018)
Inhaled Treprostinil-Prodrug Lipid Nanoparticle Formulations Provide Long-Acting Pulmonary Vasodilation
Franziska G. Leifer et al.
DRUG RESEARCH (2018)
Molecular basis of mycobacterial survival in macrophages
Jane Atesoh Awuh et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Tight junctions in pulmonary epithelia during lung inflammation
Oliver H. Wittekindt
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2017)
Patient Focus and Regulatory Considerations for Inhalation Device Design: Report from the 2015 IPAC-RS/ISAM Workshop
Nicolas Roche et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2017)
The History of Therapeutic Aerosols: A Chronological Review
Stephen W. Stein et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2017)
Preclinical Pharmacology and Pharmacokinetics of Inhaled Hexadecyl-Treprostinil (C16TR), a Pulmonary Vasodilator Prodrug
Michel R. Corboz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Identification of a Potent Phosphoinositide 3-Kinase Pan Inhibitor Displaying a Strategic Carboxylic Acid Group and Development of Its Prodrugs
Tracey Pirali et al.
CHEMMEDCHEM (2017)
The PI3K Pathway in Human Disease
David A. Fruman et al.
CELL (2017)
Randomized Trial of Liposomal Amikacin for Inhlation in Nontuberculous Mycobacterial Lung Disease
Kenneth N. Olivier et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Porous mannitol carrier for pulmonary delivery of cyclosporine A nanoparticles
Sharon Shui Yee Leung et al.
AAPS JOURNAL (2017)
New Thoughts about the Origin of Plexiform Lesions
Claudette M. St Croix et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Pulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in Rats
Vladimir Malinin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
The antimicrobial susceptibility of non-tuberculous mycobacteria
S. Cowman et al.
JOURNAL OF INFECTION (2016)
The Mucus Barrier to Inhaled Gene Therapy
Gregg A. Duncan et al.
MOLECULAR THERAPY (2016)
Development of Liposomal Ciprofloxacin to Treat Lung Infections
David Cipolla et al.
PHARMACEUTICS (2016)
Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis
Annie Pardo et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Inhaled antimicrobial therapy - Barriers to effective treatment
Jeffry Weers
ADVANCED DRUG DELIVERY REVIEWS (2015)
PI3K inhibitors in inflammation, autoimmunity and cancer
Anne-Katrien Stark et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection
Tavs Qvist et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Receptor-mediated endocytosis of macromolecules and strategy to enhance their transport in alveolar epithelial cells
Mikihisa Takano et al.
EXPERT OPINION ON DRUG DELIVERY (2015)
Aerosol Performance and Long-Term Stability of Surfactant-Associated Liposomal Ciprofloxacin Formulations with Modified Encapsulation and Release Properties
David Cipolla et al.
AAPS PHARMSCITECH (2014)
Lipid-based carriers for pulmonary products: Preclinical development and case studies in humans
David Cipolla et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Claudin-18 Deficiency Results in Alveolar Barrier Dysfunction and Impaired Alveologenesis in Mice
Michael J. LaFemina et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Drug susceptibility testing of nontuberculous mycobacteria
Jakko van Ingen et al.
FUTURE MICROBIOLOGY (2014)
Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries
Pritesh P. Jain et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Delivery of Aerosolized Liposomal Amikacin as a Novel Approach for the Treatment of Nontuberculous Mycobacteria in an Experimental Model of Pulmonary Infection
Sasha J. Rose et al.
PLOS ONE (2014)
Tobramycin Inhalation Powder in Cystic Fibrosis Patients: Response by Age Group
David E. Geller et al.
RESPIRATORY CARE (2014)
Non-Cystic Fibrosis Bronchiectasis
Pamela J. McShane et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Transforming growth factor-β1 induces bronchial epithelial cells to mesenchymal transition by activating the Snail pathway and promotes airway remodeling in asthma
Zhao-Chuan Yang et al.
MOLECULAR MEDICINE REPORTS (2013)
Liposomal formulations for inhalation
David Cipolla et al.
THERAPEUTIC DELIVERY (2013)
Nanoparticle Delivery of Cancer Drugs
Andrew Z. Wang et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Effect of Aging on Cough and Swallowing Reflexes: Implications for Preventing Aspiration Pneumonia
Satoru Ebihara et al.
LUNG (2012)
Nanoparticles as drug delivery systems
Agnieszka Z. Wilczewska et al.
PHARMACOLOGICAL REPORTS (2012)
Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin
Megan Grace et al.
THORAX (2012)
Inhaled treprostinil: a therapeutic review
Richard N. Channick et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2012)
The Pharmacological Treatment of Pulmonary Arterial Hypertension
Lyn R. Frumkin
PHARMACOLOGICAL REVIEWS (2012)
Production methods for nanodrug particles using the bottom-up approach
Hak-Kim Chan et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Septin-2 Mediates Airway Epithelial Barrier Function in Physiologic and Pathologic Conditions
Venkataramana K. Sidhaye et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
CD23-Dependent Transcytosis of IgE and Immune Complex across the Polarized Human Respiratory Epithelial Cells
Senthilkumar Palaniyandi et al.
JOURNAL OF IMMUNOLOGY (2011)
PI3Kβ Plays a Critical Role in Neutrophil Activation by Immune Complexes
Suhasini Kulkarni et al.
SCIENCE SIGNALING (2011)
The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension
Tobias Gessler et al.
Therapeutic Advances in Respiratory Disease (2011)
The role of the right ventricle in pulmonary arterial hypertension
A. Vonk Noordegraaf et al.
EUROPEAN RESPIRATORY REVIEW (2011)
Pulmonary Formulations: What Remains to be Done?
Jeffry G. Weers et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2010)
The Particle has Landed-Characterizing the Fate of Inhaled Pharmaceuticals
John S. Patton et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2010)
MEDICAL PROGRESS Airway Mucus Function and Dysfunction
John V. Fahy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Inhaled treprostinil and pulmonary arterial hypertension
Samuel T. Nadler et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2010)
TRPA1 Agonists Evoke Coughing in Guinea Pig and Human Volunteers
Mark A. Birrell et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Current Prodrug Design for Drug Discovery
Pei-Wen Hsieh et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
A Gamma Scintigraphy Study to Investigate Lung Deposition and Clearance of Inhaled Amikacin-Loaded Liposomes in Healthy Male Volunteers
Jeffry Weers et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2009)
Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum
David J. Serisier et al.
RESPIRATORY RESEARCH (2009)
Aerosolized antibiotics for non-cystic fibrosis bronchiectasis
Bruce K. Rubin
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2008)
Characterization of nebulized liposomal amikacin (Arikace™) as a function of droplet size
Zhili Li et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2008)
Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections
P. Meers et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Delivery systems to increase the selectivity of antibiotics in phagocytic cells
Elsa Briones et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: Formulation aspects and stability
Elke Kleemann et al.
PHARMACEUTICAL RESEARCH (2007)
Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis
Diana Bilton et al.
CHEST (2006)
Pathogenesis of Mycobacterium avium infection -: Typical responses to an atypical mycobacterium?
Rui Appelberg
IMMUNOLOGIC RESEARCH (2006)
Mechanistic studies of acid-evoked coughing in anesthetized guinea pigs
Brendan J. Canning et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages
M Barcia-Macay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils
AM Condliffe et al.
BLOOD (2005)
Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa
ME Drobnic et al.
ANNALS OF PHARMACOTHERAPY (2005)
Cellular pharmacokinetics and pharmaco dynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages
F Van Bambeke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells
S Amasheh et al.
JOURNAL OF CELL SCIENCE (2002)
Sex-related differences in cough reflex sensitivity in patients with chronic cough
JA Kastelik et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Human airway mucin glycosylation: A combinatory of carbohydrate determinants which vary in cystic fibrosis
G Lamblin et al.
GLYCOCONJUGATE JOURNAL (2001)
Functional modeling of tight junctions in intestinal cell monolayers using polyethylene glycol oligomers
CJ Watson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2001)
Aerosolized protein delivery in asthma: Gamma camera analysis of regional deposition and perfusion
S Sangwan et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2001)
Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis
AF Barker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression
A Cano et al.
NATURE CELL BIOLOGY (2000)
Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications
H Pinto-Alphandary et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
Share Paper
